Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10965520 | Vaccine | 2015 | 7 Pages |
Abstract
AVA was safe and immunogenic in 18 to 20 year-olds compared to 21 to 29 year-olds. These results provide initial information to anthrax and pediatric specialists if AVA studies in adolescents are required.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
James C. Jr., M.D., Yonghong Ph.D., Conrad P. Ph.D., Thomas M. Ph.D., Cabrini M.S., Eric M. Ph.D.,